K H S PHARMA HOLDING GMBH has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are THEAPRIN PHARMACEUTICALS INC, NANJING FUHAIAOSAI PHARMACEUTICAL CO LTD and AUROBINDO PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | China | 2 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kahm Andreas | 3 |
#2 | Drescher Christian | 3 |
#3 | Cadonau Stephanie | 3 |
#4 | Dworak Jürgen | 2 |
#5 | Kupka Anna | 2 |
#6 | Krebs Andreas | 2 |
#7 | Haferkamp Sven | 2 |
#8 | Bock Dominique Anna | 2 |
#9 | Kochner Arno | 2 |
#10 | Stumpf Marcus | 2 |
Publication | Filing date | Title |
---|---|---|
EP3255048A1 | Non-crystalline form of palbociclib | |
EP3219309A1 | Fixed dosed pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension | |
EP3088383A1 | Optimized synthesis of pregabalin and 4-amino butanoic acid using an improved production method of conjugated nitroalkenes | |
WO2014140318A1 | Improved process for acyl transfer reactions | |
EP2730279A1 | Immediate release formulations of cinacalcet | |
WO2012004391A1 | Process for the preparation of flupirtine maleate | |
EP2121679A1 | Method for producing azoniaspironortropine esters |